Product Code: RP-ID-10307065 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10307065
Market Overview:
Global Percutaneous Coronary Intervention Market Outlook 2027
Global Percutaneous Coronary Intervention Market Analysis – 2018-2027
Percutaneous coronary intervention is the procedure to place a stent through the help of a catheter to open up the blood vessels in the Heart, which might have been blocked due to some plaque buildup. This process helps the arteries to function properly in the cardiovascular system. The global percutaneous coronary intervention market is anticipated to record a CAGR of 5.39% over the forecast period, i.e. 2020-2027. Factors such as rising number of FDA approved products, increasing incidences of chronic cardiovascular diseases along with growing development in the healthcare sector in nations around the world are some of the factors anticipated to contribute towards the growth of the global percutaneous coronary intervention market. According to the World Health Organization (WHO), in the year 2016 the global cardiovascular disease death burden is anticipated to reach 17.9 million.
The global percutaneous coronary intervention market consists of various segments that are segmented by product, end users and by region. The end users segment is further sub-segmented into hospital, clinics, ambulatory surgical centers and research & academic institutes, out of which, hospital segment, which has a market value of USD 8702 million in the year 2018, is anticipated to grow with a CAGR of 4.95% over the forecast period. Moreover, the ambulatory surgical centers segment is anticipated to hold the largest CAGR of 6.41% over the forecast period.
Based on region, the global percutaneous coronary intervention market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in Asia Pacific, which had accounted for a value of USD 3109.73 million in the year 2018, is estimated to witness the highest CAGR of 6.08% over the forecast period owing to the rising geriatric population and the increasing demand for advanced high accuracy surgical solutions, especially from nations, such as China, Japan and India.
Some of the affluent industry leaders in the global percutaneous coronary intervention market are Abbott, Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, B. Braun Melsungen AG, Getinge AB, Terumo Corporation, Asahi Intecc Co., Ltd., Becton, Dickinson and Company and Biosensors International Group, Ltd.
Abbott, Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, B. Braun Melsungen AG, Getinge AB, Terumo Corporation, Asahi Intecc Co., Ltd., Becton, Dickinson and Company and Biosensors International Group, Ltd
Related Reports
Proof of Quality & Reliability
